Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To examine the impact of the 21-gene Oncotype DX Breast Cancer Assay on the adjuvant treatment decision-making process for early-stage breast cancer in Hong Kong.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Hong Kong Med J

Title: Hong Kong medical journal = Xianggang yi xue za zhi

ISSN: 1024-2708

ISSN (Print): 1024-2708

Publication date (Electronic): Oct 2014

Volume: 20

Issue: 5

Affiliations

[1 ] Breast Care Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

[2 ] St George's University of London, St George's Healthcare Trust, Cranmer Terrace, London SW17 0RE, United Kingdom.

[3 ] Division of Medical Oncology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.

[4 ] Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Article

DOI: 10.12809/hkmj134140

PubMed ID: 24948666

SO-VID: 53101705-6785-49b0-810f-b7427f91db16

History

Keywords: Breast neoplasms,Chemotherapy, adjuvant,Hong Kong

Data availability:

Keywords: Breast neoplasms, Chemotherapy, adjuvant, Hong Kong

Comments

Comment on this article

scite_

Cited by 3

See all cited by